|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.91 CNY | -2.62% |
|
+1.25% | -0.26% |
| May. 07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
| May. 07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
BrightGene Bio-Medical Technology Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 1,052.41 million compared to CNY 785.38 million a year ago. Net income was CNY 243.74 million compared to CNY 169.88 million a year ago.
Basic earnings per share from continuing operations was CNY 0.59 compared to CNY 0.41 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.26% | 2.03B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B | |
| -4.38% | 156B |
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. 
